MSD to Ensure Appropriate Use of Insomnia Drug Belsomra

Takahiro Oura of MSD MSD will work to ensure the appropriate use of its new insomnia treatment Belsomra (suvorexant), said Takahiro Oura who works at the company’s marketing unit. Belsomra, which was launched on November 26 in Japan ahead of...read more